| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
James R Tobin is Director at GMED and has filed Form 4s across 2 companies. From February 2019 to September 2026, the filings on record show 0 open-market purchases and 17 sales. James R Tobin's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Historically, James R Tobin's trades have earned a middling insider score of 60/100 across 13 rated trades. Over a 12-month horizon, 61.5% of those trades were profitable, with an average 12-month return of -12.7%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2022 | Director | Sale+OE | 8,850 | $65.47 | $579,418.35 | - | -13.0% | -20.3% | ||
| Mar 10, 2022 | Director | Sale+OE | 14,484 | $70.65 | $1,023,246.00 | - | -12.7% | -22.7% | ||
| May 10, 2021 | Director | Sale+OE | 25,000 | $71.96 | $1,799,000.00 | - | +12.8% | -13.8% | ||
| Feb 9, 2021 | TMDX Transmedics Group, Inc. | Director | Sell | 10,168 | $32.83 | $333,786.40 | -2.3% | - | - | |
| Sep 2, 2020 | Director | Sale+OE | 5,600 | $56.85 | $318,360.00 | - | - | - | ||
| Aug 25, 2020 | Director | Sale+OE | 17,400 | $54.40 | $946,560.00 | - | - | - | ||
| Feb 28, 2019 | Director | Sale+OE | 37,000 | $47.59 | $1,760,926.00 | - | - | - |